Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Artificial crystal with antiproliferous medicine coating for preventing and treating after-cataract forming

An intraocular lens and anti-proliferation technology, applied in intraocular lenses, prostheses, medical science, etc., can solve the problems of short corneal action time, achieve no adverse reactions, inhibit growth, and reduce the formation rate of post-developmental disorders

Inactive Publication Date: 2007-10-17
刘红玲
View PDF0 Cites 23 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] The present invention aims to solve the problem that the existing drug-loaded intraocular lens has a short action time on the cornea, and provides an intraocular lens with an anti-proliferative drug coating for preventing and preventing after-failure formation

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Artificial crystal with antiproliferous medicine coating for preventing and treating after-cataract forming
  • Artificial crystal with antiproliferous medicine coating for preventing and treating after-cataract forming

Examples

Experimental program
Comparison scheme
Effect test

specific Embodiment approach 1

[0005] Specific embodiment one: In this embodiment, the intraocular lens with anti-proliferative drug coating for prevention and treatment of post-developmental disorder is made of a common intraocular lens and a coating containing anti-proliferative drug, wherein the coating containing anti-proliferative drug is bonded On the surface of ordinary intraocular lenses, the thickness of the coating is 3 to 20 microns.

specific Embodiment approach 2

[0006] Embodiment 2: The difference between this embodiment and Embodiment 1 is that the coating with anti-proliferative drugs can be applied to the non-optical zone part of the edge of the ordinary intraocular lens and the loops of the lens, the loops of the ordinary intraocular lens, the ordinary intraocular lens, etc. The surface of the intraocular lens and the haptics of the lens or the non-corneal contact surface of the ordinary IOL and the haptics of the lens. Other compositions are the same as in Embodiment 1.

specific Embodiment approach 3

[0007] Specific embodiment three: the difference between this embodiment and specific embodiment one is that ordinary intraocular lenses are polymethyl methacrylate intraocular crystals, silicone gel crystals, glass crystals, hydrogels, polycarbonate, polysiloxane Or one of the folding intraocular lenses made of silicone gel and hydrogel. Other compositions are the same as in Embodiment 1.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Thicknessaaaaaaaaaa
Thicknessaaaaaaaaaa
Login to View More

Abstract

An artificial lens having stents coated with antiproliferative agents for prevention and treatment of the posterior capsule opacification, the invention relates to an artificial lens having stents coating for solving problems of time of present artificial lens loaded with medicine acting on cornea is short. The artificial lens having stents coated with antiproliferative agents for prevention and treatment of the posterior capsule opacification is prepared by ordinary artificial lens and coating with antiproliferative agents, wherein the coating with antiproliferative agents adheres on surface of ordinary artificial lens, thickness of the coating is 3 to 20 mum. The invention adopts macomolecule coating material to coat antiproliferative agents on artificial lens, slowly releases agents in capsules and ambitus cells, represses generation of lens epithelial cell, prevents and cures formation of the posterior capsule opacification. The agents of the invention act on cornea long time, capable of releasing effectively 90 to 120 days, have good therapeutic, patients use the artificial lens of the invention, formation rate of the posterior capsule opacification reduced greatly from more than 60% to 10% and without untoward reaction.

Description

technical field [0001] The invention relates to an artificial lens with drug coating. Background technique [0002] Posterior capsule opacification (PCO) is the most common complication after cataract and intraocular lens implantation, with an incidence rate as high as 60%, and the incidence rate of postoperative disorder in children with congenital cataract and intraocular lens implantation is as high as 100% , people are constantly exploring the effective methods of prevention and treatment of post-developmental disorder. The reason for the formation of after-growth disorder is currently considered to be that the main reason for the formation of after-growth disorder is that the residual lens epithelial cells (lensepithelium cells, IECs) after cataract surgery proliferate, migrate and transform into fibroblasts in the posterior capsule, forming fibrous membranes and forming fibroblasts. It leads to the turbidity of the posterior capsule, and the existence of the posterior...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61L27/54A61L27/40A61F2/16
Inventor 刘红玲张晓梅程树军杨巍
Owner 刘红玲
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com